On average, the above 10 stocks were UP 7.4% during the first week of May but are now DOWN 7.6%...
There are more than 480 naturally occurring compounds present in the cannabis plant, more than 100 of which are considered to be cannabinoids. One of those...
If we accept as fact that The Last of Us, the 2013 PlayStation 3 video game from a studio called Naughty Dog, is a remarkable achievement...
Filamentous fungi have long been a good friend of sake brewers, but they might soon also be a sidekick for environmentalists. Osaka Metropolitan University...
Moderna CEO Stéphane Bancel is revving the engines going into 2023, with a whopping $4.5 billion R&D budget and a new priority review voucher. The...
The article Prince Harry Admits Psychedelics Helped His Mental Health was originally published on Microdose. From famous athletes to movie stars, we can...
MAPS Policy Director Ismail Alitalks what it means for the psychedelics industry. The post Congress Hops on Psychedelics Juggernaut with a New Caucus appeared...
I am optimistic that the market will perform better in 2023 and think the sell-off could be a great opportunity to invest in some of those...
MAPS Public Benefit Corporation, a private biopharmaceutical company dedicated to the development and commercialization of psychedelic medicines, announced...
It seems it is business as usual for Mind Medicine, aka MindMed, (NASDAQ: MNMD) as the firm gave updates on The post MindMed Expects Results For...
The article Secretive GH Research Provides Business Updates and Upcoming Milestones was originally published on Microdose. Secretive psychedelic drug...
Reunion will present findings to the FDA. The post Postpartum Depression Psychedelic Treatment Studied In Reunion’s Phase 1 Trial appeared first on Green...
Cybin, a biopharmaceutical company focused on progressing Psychedelics to Therapeutics outlined its upcoming priorities and near-term milestones that...
Nintendo World is coming to the US for theme park guests looking to level up their vacation experience.
A new publication from Opto-Electronic Advances, 10.29026/oea.2022.210105 discusses other pathways towards a more sustainable electrocatalyst for efficient...
The early results of a COMPASS Pathways clinical trial quell some concerns related to the safety of psychedelic therapy for individuals with bipolar disorder. The...